– Prestigious Law Firm Files Class Action Lawsuit Against Canadian …

A class action lawsuit has been filed against Canadian banks CIBC and RBC by Paul Durkacz, a shareholder of Quantum BioPharma Ltd (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91). This lawsuit alleges that shareholders of Quantum BioPharma were subjected to illegal stock manipulation between January 6, 2021, and October 15, 2025. The investors who sold securities of Quantum BioPharma Ltd, previously known as FSD Pharma Inc., were allegedly affected significantly and materially by these actions.

The lawsuit, brought forward by Paul Durkacz, claims that there was deliberate manipulation of Quantum BioPharma shares on the stock market. This supposed manipulation occurred over several years, spanning from 2021 to 2025, during which shareholders selling securities of Quantum BioPharma Ltd, later rebranded from FSD Pharma Inc., suffered substantial losses. The lawsuit asserts that this stock market manipulation had a harmful impact on investors in Quantum BioPharma.

The allegations put forth in the class action lawsuit against Canadian banks CIBC and RBC suggest that there was an orchestrated effort to manipulate the stock prices of Quantum BioPharma. According to the lawsuit, shareholders who sold Quantum BioPharma securities faced significant financial harm resulting from these illegal activities. The lawsuit claims that these actions had a detrimental effect on investors involved with Quantum BioPharma during the specified timeframe.

The claim made by Paul Durkacz in the class action lawsuit against CIBC and RBC raises serious concerns about the alleged stock market manipulation of Quantum BioPharma shares. The lawsuit argues that shareholders of Quantum BioPharma were unfairly impacted by the manipulation of the stock prices, causing them substantial financial losses. The lawsuit seeks to hold the Canadian banks accountable for their alleged involvement in the illegal activities surrounding Quantum BioPharma shares.

In conclusion, the class action lawsuit filed by Paul Durkacz against Canadian banks CIBC and RBC sheds light on the alleged illegal stock market manipulation of Quantum BioPharma shares. The lawsuit highlights the significant financial harm suffered by shareholders of Quantum BioPharma due to these purported manipulative actions. The legal action aims to address the alleged wrongdoing and bring justice to the investors affected by the supposed stock market manipulation.